Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ZLAB
ZLAB logo

ZLAB Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Zai Lab Ltd (ZLAB) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
20.090
1 Day change
6.83%
52 Week Range
44.340
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Zai Lab Ltd (ZLAB) is not a strong buy for a beginner, long-term investor at this time. The technical indicators are bearish, insider selling has significantly increased, and the financial performance shows declining net income and EPS. While analysts maintain an overall positive outlook with price targets significantly above the current price, the lack of recent positive news, weak financial growth trends, and bearish technicals suggest waiting for a better entry point.

Technical Analysis

The technical indicators for ZLAB are bearish. The MACD is negative and expanding downward, RSI is neutral at 34.958, and the moving averages show a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below its pivot level of 18.332, with support at 17.549 and resistance at 19.115.

Options Data

Bearish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

The high Put-Call ratios indicate bearish sentiment in the options market. Implied volatility is high at 131.12, with an IV percentile of 97.61, suggesting elevated uncertainty.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
7
Buy
7

Positive Catalysts

  • Revenue increased by 16.99% YoY in Q4 2025.

Neutral/Negative Catalysts

  • Insider selling has surged by 1089.28% in the last month. Net income and EPS have declined significantly (-38.29% and -37.50% YoY, respectively). Gross margin also dropped slightly (-2.17% YoY). The MACD and moving averages indicate a bearish trend.

Financial Performance

In Q4 2025, revenue increased by 16.99% YoY to $127.6M, but net income dropped by 38.29% YoY to -$50.41M. EPS decreased by 37.50% YoY to -$0.05, and gross margin declined slightly to 60.08% (-2.17% YoY).

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts maintain a positive outlook with Overweight/Buy ratings. However, multiple firms have recently lowered their price targets, citing modest growth expectations and pricing pressures in China. Current price targets range from $32 to $47, significantly above the current price of $17.97.

Wall Street analysts forecast ZLAB stock price to rise
5 Analyst Rating
Wall Street analysts forecast ZLAB stock price to rise
4 Buy
1 Hold
0 Sell
Strong Buy
Current: 18.810
sliders
Low
25.7
Averages
47.93
High
74
Current: 18.810
sliders
Low
25.7
Averages
47.93
High
74
JPMorgan
Anupam Rama
Overweight
downgrade
$39 -> $32
AI Analysis
2026-03-18
Reason
JPMorgan
Anupam Rama
Price Target
$39 -> $32
AI Analysis
2026-03-18
downgrade
Overweight
Reason
JPMorgan analyst Anupam Rama lowered the firm's price target on Zai Lab to $32 from $39 and keeps an Overweight rating on the shares. The firm updated models in the smid-cap biotechnology space.
Cantor Fitzgerald
Overweight
downgrade
$55 -> $37
2026-02-27
Reason
Cantor Fitzgerald
Price Target
$55 -> $37
2026-02-27
downgrade
Overweight
Reason
Cantor Fitzgerald lowered the firm's price target on Zai Lab to $37 from $55 and keeps an Overweight rating on the shares. Zai Lab reported Q4 and full-year revenues of $127.6M and $460.2M, respectively, in line with consensus, though Vyvgart sales were slightly weaker than expected, the analyst tells investors in a research note. Management indicated that 2026 top-line growth is likely to be modest, with volume gains offset by pricing pressures and competition in China, the firm says.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for ZLAB
Unlock Now

People Also Watch